Shaping the Future of Cancer Care Through Immuno-Oncology

In the ever-evolving world of cancer treatment, immuno-oncology (IO) continues to stand at the forefront of innovation. With recent FDA approvals for TIL therapies and bispecific antibodies, and new developments in CAR-T technologies, the field is rapidly expanding into combination-based strategies that integrate with standard care. Researchers are also exploring how to overcome challenges posed by the tumor microenvironment and immune cell exhaustion to increase therapeutic success rates.

How can scientists and biotech innovators harness the immune system more effectively to combat cancer—and what does the next generation of immuno-oncology look like?

On this episode of Crowncast by Crown BioScience, host Jonny McMichael welcomes Gera Goverse, Director of Immuno-Oncology at Crown BioScience, for a deep dive into the scientific advances and strategic considerations shaping immuno-oncology today. From bispecifics and checkpoint inhibitors to personalized and allogeneic CAR-T therapies, they explore the complexity of immune response modeling, the need for combination therapies, and how the tumor microenvironment impacts treatment outcomes.

Key discussion points from this episode:

  • The rise of combination therapies and their role in overcoming immune resistance

  • Emerging innovations in CAR-T design to address exhaustion and broaden application

  • The critical importance of tumor microenvironment and model precision in preclinical research

About the Guest:
Dr. Gera Goverse is an accomplished immunologist with a PhD from Amsterdam UMC and a postdoctoral fellowship at KU Leuven. She has over a decade of experience in immunology and oncology, having transitioned from academia to biotech, where she now leads the immuno-oncology efforts at Crown BioScience Netherlands following their merger with organoid research CRO Ocello.

Recent Episodes

Dr. Sam Ambewadikar returns to break down Anthem’s Whole Health Index (WHI)—a powerful tool that distills medical, social, environmental, and behavioral data into a single score (0–100) to identify members most at risk. By surfacing factors like transportation deserts, housing instability, or food insecurity, WHI enables Anthem care managers and advocates to proactively match members…

Dr. Sam Ambewadikar, RVP and Medical Director at Anthem National Accounts, joins Brent to unpack the power of primary care attribution analysis—a tool he helped pioneer to spotlight the clinical and financial impact of members not having an established PCP. Drawing from his background as a practicing pediatrician and claims analytics leader, Dr. Sam shares…

In this episode, Christina Firouztash, Executive Advisor of Digital Solutions at Anthem, gives a dynamic walkthrough of the Sydney Health app—Anthem’s flagship digital member experience. Christina showcases how Sydney delivers personalized, simple, and equitable navigation across benefits, including virtual care, pharmacy, financial transparency, and social services access. From contextual chatbots and ID card access to…